Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Neuroblastoma and UGT1A1[original query] |
|---|
| Phase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma. British journal of cancer 2015 Feb 112 (4): 644-9. DuBois S G, Allen S, Bent M, Hilton J F, Hollinger F, Hawkins R, Courtier J, Mosse Y P, Matthay K |
| Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen. Pharmacogenomics and personalized medicine 2021 14 369-377. Zhu Xiaoqin, Zhu Jia, Sun Feifei, Zhen Zijun, Zhou Dalei, Lu Suying, Huang Junting, Que Yi, Zhang Lian, Cai Ruiqing, Wang Juan, Zhang Yizh |
| Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study. Cells 2021 Feb 10 (2): . Seyed Khoei Nazlisadat, Carreras-Torres Robert, Murphy Neil, Gunter Marc J, Brennan Paul, Smith-Byrne Karl, Mariosa Daniela, Mckay James, O'Mara Tracy A, Jarrett Ruth, Hjalgrim Henrik, Smedby Karin E, Cozen Wendy, Onel Kenan, Diepstra Arjan, Wagner Karl-Heinz, Freisling Hei |
| Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma. Cancer medicine 2022 Mar . Imaya Masayuki, Muramatsu Hideki, Narita Atsushi, Yamamori Ayako, Wakamatsu Manabu, Yoshida Taro, Miwata Shunsuke, Narita Kotaro, Ichikawa Daisuke, Hamada Motoharu, Nishikawa Eri, Kawashima Nozomu, Nishio Nobuhiro, Kojima Seiji, Takahashi Yoshiyu |
- Page last reviewed:Feb 1, 2024
- Content source: